Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +1.05% | 0.00% | +123.08% |
Jun. 04 | LadRx Corporation and ImmunityBio, Inc. Mutually Agree to Terminate Aldoxorubicin License | CI |
May. 15 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+123.08% | 1.44M | |
+55.70% | 59.34B | |
+43.00% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+2.72% | 12.49B | |
+25.85% | 12.28B |
- Stock Market
- Equities
- LADX Stock
- News LadRx Corporation
- CytRx Corporation Announces Board Changes